April 18, 2008 (Chicago, Illinois) — A new study finds that the use of drugs with anticholinergic activity is associated with a more rapid decline in cognitive performance in older individuals. The ...

A new study suggests anticholinergic medications may increase the risk of accelerated cognitive decline, especially in older adults at high risk of developing Alzheimer’s disease. Share on Pinterest A ...

A class of drug commonly used to treat everything from chronic obstructive pulmonary disease (COPD) to depression has now been linked to accelerating the loss of mobility in older age. This adds a new ...

The primary finding of this study is that prescriptions for anticholinergics were documented in 21% of children and adolescents receiving antipsychotics for various psychiatric disorders. Utilization ...

Physicians should carefully weigh the risks against the potential benefits before prescribing anticholinergics, according to investigators. A new systematic review and meta-analysis confirms a link ...

With vanishingly few exceptions, we do not understand the underlying causes of dementia. A new study adds evidence to the hypothesis that unintended side-effects of anticholinergics may be involved.

Among patients with overactive bladder (OAB), anticholinergic medication use appears to be associated with an increased risk of new onset dementia when compared with beta-3 agonist use, according to ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ENGLAND — Scientists have long found a ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of dementia. You will find what these drugs treat, the evidence connecting them to ...

IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences (Nasdaq: UROV) today announced positive efficacy and safety data from the vibegron EMPOWUR long term extension study with patient ...

Virtus announced a voluntary recall of 7 lots of Hyoscyamine Sulfate 0.125mg due to both superpotent and subpotent test results. Hyoscyamine sulfate is an anticholinergic agent used as adjunctive ...